Fulcrum Therapeutics, Inc. (FULC)

Typically moves ±13.42% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-07-28 APPROXIMATE

Since Aug 26, 2019, Fulcrum Therapeutics, Inc. (FULC) has reported earnings 28 times. On average the shares move ±13.42% post-earnings, with a positive reaction 57.1% of the time. Its largest post-earnings gain was +125.33% (Aug 10, 2021) and its largest decline was -48.01% (Aug 11, 2020). The next earnings report is predicted for 2026-07-28 (approximate).

Earnings reactions

How FULC moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±13.42%

Positive %

57.1%

Negative %

42.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Apr 27, 2026	☀ PRE	-1.53%	open_in_new
Feb 24, 2026	☀ PRE	-21.21%	open_in_new
Oct 29, 2025	☀ PRE	-6.4%	open_in_new
Jul 29, 2025	☀ PRE	-2.82%	open_in_new
May 01, 2025	☀ PRE	+13.77%	open_in_new
Feb 25, 2025	☀ PRE	+0%	open_in_new
Nov 13, 2024	☀ PRE	-2.2%	open_in_new
Jul 31, 2024	☀ PRE	+10.34%	open_in_new
May 13, 2024	☀ PRE	-1.61%	open_in_new
Feb 27, 2024	☀ PRE	+4.62%	open_in_new
Nov 07, 2023	☀ PRE	+19.5%	open_in_new
Aug 03, 2023	☀ PRE	+0.79%	open_in_new
May 15, 2023	☀ PRE	+11.31%	open_in_new
Mar 09, 2023	☀ PRE	-23%	open_in_new
Nov 08, 2022	☀ PRE	+14.97%	open_in_new
Aug 11, 2022	☀ PRE	-2.45%	open_in_new
May 09, 2022	☀ PRE	-11.24%	open_in_new
Mar 03, 2022	☀ PRE	+5.41%	open_in_new
Nov 04, 2021	☀ PRE	+3.27%	open_in_new
Aug 10, 2021	☀ PRE	+125.33%	open_in_new
May 06, 2021	☀ PRE	+5.06%	open_in_new
Mar 04, 2021	☀ PRE	-14.32%	open_in_new
Nov 10, 2020	☀ PRE	+1.11%	open_in_new
Aug 11, 2020	☀ PRE	-48.01%	open_in_new
May 13, 2020	☀ PRE	+10.53%	open_in_new
Mar 05, 2020	☀ PRE	+2.78%	open_in_new
Nov 14, 2019	☀ PRE	-3.29%	open_in_new
Aug 26, 2019	☀ PRE	+8.78%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±13.42%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 17 →

Funds holding

$80774087

Total value held

Buying

13 added · 4 reduced

Blackrock, Inc.

$41345848 +26.43%

Gsk Plc

$13696426 NEW BUY

State Street Corp

$11887357 +54.16%

Goldman Sachs Group Inc

$4386542 +76.58%

Northern Trust Corp

$3627795 -14.35%

SEC Filing Types

description SCHEDULE 13G/A

11 chevron_right

description 424B5

11 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260720	open_in_new SEC.gov
SCHEDULE 13G	20260717	open_in_new SEC.gov
3	20260715	open_in_new SEC.gov
4	20260715	open_in_new SEC.gov
SCHEDULE 13G/A	20260715	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov

Frequently asked about FULC earnings

When does Fulcrum Therapeutics, Inc. report earnings next? expand_more

Fulcrum Therapeutics, Inc. (FULC)'s next earnings date is approximate for 2026-07-28. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does FULC stock move after earnings? expand_more

Over 28 reports, FULC has moved an average of ±13.42% the session after earnings, closing higher 57.1% of the time.

What was FULC's biggest post-earnings move? expand_more

FULC's largest post-earnings gain on record was +125.33% on Aug 10, 2021, and its largest decline was -48.01% on Aug 11, 2020.

Where can I find Fulcrum Therapeutics, Inc.'s SEC filings? expand_more

All of Fulcrum Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.